Back to search

Article

FAP+ cells restrict antibody drug delivery and promote an immunosuppressive environment in head and neck squamous cell carcinoma.

2025-03-25

Abstract excerpt

<title>Abstract</title> <p>Background Antibody-based therapies (such as anti-EGFR and anti-PD1/L1 agents) have altered the landscape of cancer treatment to improve patient outcomes in formerly unresponsive tumor types. However, this robust response is not ubiquitous for all patients or cancer subtypes. Head and neck squamous cell carcinoma continues to have reduced response in many patient populations regardless...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
905ed055-cc56-5e4f-993a-4e8faf92ca82
DOI
10.21203/rs.3.rs-6228925/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FAP+ cells restrict antibody drug delivery and promote an immunosuppressive environment in head and neck squamous cell carcinoma.DOI 10.21203/rs.3.rs-6228925/v1
Select a neighboring publication to make it the new centre.